Thomas Edward Hamilton, Director at Larimar Therapeutics, Inc. (LRMR), bought 113,420 shares at $8.75 ($992K) on 2021-06-30, disclosed to the SEC on 2021-07-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.75 | 56,710 | $496K | 50.0% |
| 2 | $8.75 | 56,710 | $496K | 50.0% |
| Total | $8.75 avg | 113,420 | $992K | 100% |
| Filing → |
| LRMR | BUY | 2024-05-31 | $1000K | — | Filing → |
| LRMR | BUY | 2022-09-20 | $1000K | — | Filing → |
| NLY | SELL | 2021-05-04 | $734K | — | Filing → |